Introduction
Fondita European Small Cap invests in smaller quality companies in Europe with a market capitalization of less than 4 billion euros.
The fund invests in companies that are often niche players with strong market positions in their respective industries. The fund has a broad industry distribution with companies within medical technology,industrials and consumer related activities. Here we find companies with good growth opportunities creating added value in the long term. Small quality companies are also attractive takeover candidates.
The fund does not invest in shares of Eastern European companies.
Fund facts
| Fund size | 64,4 MEUR |
| Fund unitholders | 361 |
| ISIN (A) | FI0008814686 |
| ISIN (B) | FI0008814694 |
| Legal structure | UCITS |
| Currency | EUR |
| Management fee | 2,00 % p.a. |
| Risk profile | 6/7 |
Top 5 Holdings
| Dermapharm Holding (DE) | 6,8 % |
| Reply (IT) | 6,2 % |
| Siegfried Holdning (CH) | 6,1 % |
| Solutions 30 (FR) | 5,5 % |
| All for One Group (DE) | 5,1 % |
Top 5 Countries
| Germany | 31 % |
| Switzerland | 19 % |
| Netherlands | 10 % |
| Italy | 9 % |
| Great Britain | 6 % |
Return
| Return | Fund | Index |
|---|---|---|
| 1 month | 4,0 % | 5,7 % |
| 3 months | 3,9 % | 8,3 % |
| 6 months | -3,3 % | -0,2 % |
| YTD | -13,4 % | -9,8 % |
| 1 year | -3,0 % | 4,4 % |
| 3 years | -3,6 % | 7,0 % |
| 5 years | 22,3 % | 25,6 % |
| 10 years | 144,4 % | 164,8 % |
| since launch (19.5.2009) | 226,2 % | 265,3 % |
| since launch p.a. | 11,0 % | 12,2 % |
(Index = MSCI Europe Small Cap NR EUR)
Portfolio managers
Sector Division
| Information Technology | 39 % |
| Health Care | 28 % |
| Industrials | 17 % |
| Materials | 10 % |
| Communication Services | 5 % |
| Real Estate | 2 % |
| Cash | -1 % |
Top 10 Holdings
| Dermapharm Holding (DE) | 6,8 % |
| Reply (IT) | 6,2 % |
| Siegfried Holdning (CH) | 6,1 % |
| Solutions 30 (FR) | 5,5 % |
| All for One Group (DE) | 5,1 % |
| CANCOM (DE) | 5,0 % |
| Corbion (NL) | 4,3 % |
| Softcat (GB) | 4,3 % |
| Also Holding (CH) | 4,2 % |
| CompuGroup Medical (DE) | 4,1 % |
Country Division
| Germany | 31 % |
| Switzerland | 19 % |
| Netherlands | 10 % |
| Italy | 9 % |
| Great Britain | 6 % |
| France | 6 % |
| Spain | 5 % |
| Sweden | 4 % |
| Belgium | 3 % |
| Norway | 3 % |
| Portugal | 3 % |
| Austria | 2 % |
Currency Exposure
| EUR | 69 % |
| CHF | 19 % |
| GBP | 6 % |
| SEK | 4 % |
| NOK | 3 % |
The past performance of the investment fund does not provide any guarantee of future results. Depending on market conditions, the fund unit value may rise or fall.
Risk Profile
- 1
- 2
- 3
- 4
- 5
- 6
- 7
Less risk
More risk
A high number means that the fund has a higher risk and that the value of the fund can vary greatly. This means that both return and risk potential is greater.
Return
| Return | Fund | Index |
|---|---|---|
| 1 month | 4,0 % | 5,7 % |
| 3 months | 3,9 % | 8,3 % |
| 6 months | -3,3 % | -0,2 % |
| YTD | -13,4 % | -9,8 % |
| 1 year | -3,0 % | 4,4 % |
| 3 years | -3,6 % | 7,0 % |
| 5 years | 22,3 % | 25,6 % |
| 10 years | 144,4 % | 164,8 % |
| since launch (19.5.2009) | 226,2 % | 265,3 % |
| since launch p.a. | 11,0 % | 12,2 % |
(Index = MSCI Europe Small Cap NR EUR)
Std Dev
| 3 years | 25,2 % |
| Launch | 22,8 % |
Sharpe
| 3 years | -0,03 |
| Launch | 0,56 |
Fees
| TER | 2,00 % |
| Subscription fee | 0,00 % |
| Redemption fee | 1,00 % |
Total client relationship allow for changes in tariff rate.
Downloadable Documents
31.8.2020